Cargando…

Erdafitinib for locally advanced or metastatic urothelial carcinoma

Detalles Bibliográficos
Autores principales: Siefker-Radtke, Arlene O, Loriot, Yohann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128815/
https://www.ncbi.nlm.nih.gov/pubmed/35147178
http://dx.doi.org/10.1093/ajhp/zxac030
_version_ 1784712623645786112
author Siefker-Radtke, Arlene O
Loriot, Yohann
author_facet Siefker-Radtke, Arlene O
Loriot, Yohann
author_sort Siefker-Radtke, Arlene O
collection PubMed
description
format Online
Article
Text
id pubmed-9128815
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-91288152022-05-25 Erdafitinib for locally advanced or metastatic urothelial carcinoma Siefker-Radtke, Arlene O Loriot, Yohann Am J Health Syst Pharm Letters Oxford University Press 2022-02-11 /pmc/articles/PMC9128815/ /pubmed/35147178 http://dx.doi.org/10.1093/ajhp/zxac030 Text en © American Society of Health-System Pharmacists 2022. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Letters
Siefker-Radtke, Arlene O
Loriot, Yohann
Erdafitinib for locally advanced or metastatic urothelial carcinoma
title Erdafitinib for locally advanced or metastatic urothelial carcinoma
title_full Erdafitinib for locally advanced or metastatic urothelial carcinoma
title_fullStr Erdafitinib for locally advanced or metastatic urothelial carcinoma
title_full_unstemmed Erdafitinib for locally advanced or metastatic urothelial carcinoma
title_short Erdafitinib for locally advanced or metastatic urothelial carcinoma
title_sort erdafitinib for locally advanced or metastatic urothelial carcinoma
topic Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128815/
https://www.ncbi.nlm.nih.gov/pubmed/35147178
http://dx.doi.org/10.1093/ajhp/zxac030
work_keys_str_mv AT siefkerradtkearleneo erdafitinibforlocallyadvancedormetastaticurothelialcarcinoma
AT loriotyohann erdafitinibforlocallyadvancedormetastaticurothelialcarcinoma